Showing 1 to 8 of 8 results
Cancer Drugs Show Promise in Reversing Alzheimer's in Mice
Research shows that the FDA-approved cancer drugs letrozole and irinotecan, when combined, reduced brain degeneration and improved memory in mice, offering a potential new Alzheimer's treatment that could significantly reduce development time and cost.
Cancer Drugs Show Promise in Reversing Alzheimer's in Mice
Research shows that the FDA-approved cancer drugs letrozole and irinotecan, when combined, reduced brain degeneration and improved memory in mice, offering a potential new Alzheimer's treatment that could significantly reduce development time and cost.
Progress
48% Bias Score
Losartan Shows Promise for Butterfly Skin, but Funding for Clinical Trial Remains a Challenge
Losartan, a hypertension drug, shows promise in treating epidermolysis bullosa (butterfly skin) lesions, but a €5-10 million clinical trial is needed for EMA approval, highlighting challenges in repurposing drugs for rare diseases.
Losartan Shows Promise for Butterfly Skin, but Funding for Clinical Trial Remains a Challenge
Losartan, a hypertension drug, shows promise in treating epidermolysis bullosa (butterfly skin) lesions, but a €5-10 million clinical trial is needed for EMA approval, highlighting challenges in repurposing drugs for rare diseases.
Progress
36% Bias Score
AI Finds Life-Saving Drug for Terminally Ill Patient
An AI identified adalimumab, a drug used for arthritis and Crohn's disease, as a life-saving treatment for a terminally ill patient with idiopathic multicentric Castleman's disease (iMCD), who is now in remission almost two years after entering hospice care.
AI Finds Life-Saving Drug for Terminally Ill Patient
An AI identified adalimumab, a drug used for arthritis and Crohn's disease, as a life-saving treatment for a terminally ill patient with idiopathic multicentric Castleman's disease (iMCD), who is now in remission almost two years after entering hospice care.
Progress
40% Bias Score
Weight-Loss Drugs Show Promise in Treating Multiple Diseases, but Risks Remain
A Nature Medicine study shows weight-loss drugs like Wegovy and Ozempic effectively treat various diseases by reducing obesity and inflammation, potentially lowering Alzheimer's risk by 12%, but also carry risks of gastrointestinal issues, hypotension, and kidney problems.
Weight-Loss Drugs Show Promise in Treating Multiple Diseases, but Risks Remain
A Nature Medicine study shows weight-loss drugs like Wegovy and Ozempic effectively treat various diseases by reducing obesity and inflammation, potentially lowering Alzheimer's risk by 12%, but also carry risks of gastrointestinal issues, hypotension, and kidney problems.
Progress
24% Bias Score
Multi-Drug Resistant Tuberculosis: A Growing Global Health Crisis
In 2023, 1.25 million deaths resulted from multi-drug resistant tuberculosis (MDR-TB), exceeding COVID-19 as the leading infectious disease killer; researchers are exploring non-antibiotic drug repositioning strategies to combat rifampicin resistance and improve treatment.
Multi-Drug Resistant Tuberculosis: A Growing Global Health Crisis
In 2023, 1.25 million deaths resulted from multi-drug resistant tuberculosis (MDR-TB), exceeding COVID-19 as the leading infectious disease killer; researchers are exploring non-antibiotic drug repositioning strategies to combat rifampicin resistance and improve treatment.
Progress
24% Bias Score
Repurposed Drugs Offer Hope in Fight Against UK's Top Killer, Dementia
Dementia is the UK's biggest killer, but research suggests existing drugs like aspirin, statins, and Ozempic could prevent it, offering a cheaper alternative to recently developed, costly medications.
Repurposed Drugs Offer Hope in Fight Against UK's Top Killer, Dementia
Dementia is the UK's biggest killer, but research suggests existing drugs like aspirin, statins, and Ozempic could prevent it, offering a cheaper alternative to recently developed, costly medications.
Progress
48% Bias Score
Common Drugs May Reduce Dementia Risk: Large-Scale Study
A study of over 130 million people found that common drugs like ibuprofen and antibiotics may reduce the risk of dementia, supporting the theory that infections might trigger some forms of the disease; however, experts say more research is needed.
Common Drugs May Reduce Dementia Risk: Large-Scale Study
A study of over 130 million people found that common drugs like ibuprofen and antibiotics may reduce the risk of dementia, supporting the theory that infections might trigger some forms of the disease; however, experts say more research is needed.
Progress
40% Bias Score
Repurposing Existing Drugs Shows Promise in Dementia Treatment
A study analyzing data from over 130 million individuals found an association between antibiotics, antivirals, vaccines, and a reduced risk of dementia, suggesting that infections may trigger the disease and highlighting the potential of drug repurposing to accelerate treatment development.
Repurposing Existing Drugs Shows Promise in Dementia Treatment
A study analyzing data from over 130 million individuals found an association between antibiotics, antivirals, vaccines, and a reduced risk of dementia, suggesting that infections may trigger the disease and highlighting the potential of drug repurposing to accelerate treatment development.
Progress
16% Bias Score
Showing 1 to 8 of 8 results